photobyphm /
14 March 2019Americas

PTAB invalidates Prevnar 13 patent

American pharmaceutical company  Merck & Co. has secured a victory against its rival  Pfizer in an inter partes review of a patent concerning Prevnar 13, the biggest-selling vaccine in the world.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at